vs
Astrana Health, Inc.（ASTH）与Freedom Holding Corp.（FRHC）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是Freedom Holding Corp.的1.5倍（$950.5M vs $628.6M），Freedom Holding Corp.净利率更高（12.1% vs 0.7%，领先11.4%），Astrana Health, Inc.同比增速更快（42.9% vs -4.1%），Freedom Holding Corp.自由现金流更多（$651.7M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 16.3%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
Freedom Holding Corp.是在美国内华达州注册的投资集团，业务覆盖零售证券经纪交易、资产管理、资本市场服务、投研咨询、投行承销、抵押贷款、保险、银行及其他消费金融服务，核心布局美股、欧洲及以哈萨克斯坦为核心的中亚市场。
ASTH vs FRHC — 直观对比
营收规模更大
ASTH
是对方的1.5倍
$628.6M
营收增速更快
ASTH
高出46.9%
-4.1%
净利率更高
FRHC
高出11.4%
0.7%
自由现金流更多
FRHC
多$657.7M
$-6.0M
两年增速更快
ASTH
近两年复合增速
16.3%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $628.6M |
| 净利润 | $6.6M | $76.2M |
| 毛利率 | — | 96.0% |
| 营业利润率 | 1.9% | 14.9% |
| 净利率 | 0.7% | 12.1% |
| 营收同比 | 42.9% | -4.1% |
| 净利润同比 | 184.4% | -2.6% |
| 每股收益（稀释后） | $0.12 | $1.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHFRHC
| Q4 25 | $950.5M | $628.6M | ||
| Q3 25 | $956.0M | $526.1M | ||
| Q2 25 | $654.8M | $533.4M | ||
| Q1 25 | $620.4M | $363.7M | ||
| Q4 24 | $665.2M | $655.2M | ||
| Q3 24 | $478.7M | $580.9M | ||
| Q2 24 | $486.3M | $450.7M | ||
| Q1 24 | $404.4M | $464.7M |
净利润ASTHFRHC
| Q4 25 | $6.6M | $76.2M | ||
| Q3 25 | $373.0K | $38.7M | ||
| Q2 25 | $9.4M | $30.4M | ||
| Q1 25 | $6.7M | $-142.7M | ||
| Q4 24 | $-7.8M | $78.3M | ||
| Q3 24 | $16.1M | $114.7M | ||
| Q2 24 | $19.2M | $34.4M | ||
| Q1 24 | $14.8M | $95.2M |
毛利率ASTHFRHC
| Q4 25 | — | 96.0% | ||
| Q3 25 | — | 97.1% | ||
| Q2 25 | — | 97.4% | ||
| Q1 25 | — | 96.6% | ||
| Q4 24 | — | 98.6% | ||
| Q3 24 | — | 99.1% | ||
| Q2 24 | — | 99.0% | ||
| Q1 24 | — | — |
营业利润率ASTHFRHC
| Q4 25 | 1.9% | 14.9% | ||
| Q3 25 | 2.0% | 11.5% | ||
| Q2 25 | 3.1% | 7.6% | ||
| Q1 25 | 3.3% | -42.7% | ||
| Q4 24 | 0.1% | 15.0% | ||
| Q3 24 | 5.9% | 22.1% | ||
| Q2 24 | 6.2% | 9.2% | ||
| Q1 24 | 7.5% | 22.5% |
净利率ASTHFRHC
| Q4 25 | 0.7% | 12.1% | ||
| Q3 25 | 0.0% | 7.4% | ||
| Q2 25 | 1.4% | 5.7% | ||
| Q1 25 | 1.1% | -39.2% | ||
| Q4 24 | -1.2% | 11.9% | ||
| Q3 24 | 3.4% | 19.7% | ||
| Q2 24 | 3.9% | 7.6% | ||
| Q1 24 | 3.7% | 20.5% |
每股收益（稀释后）ASTHFRHC
| Q4 25 | $0.12 | $1.25 | ||
| Q3 25 | $0.01 | $0.63 | ||
| Q2 25 | $0.19 | $0.50 | ||
| Q1 25 | $0.14 | $-2.35 | ||
| Q4 24 | $-0.14 | $1.29 | ||
| Q3 24 | $0.33 | $1.89 | ||
| Q2 24 | $0.40 | $0.57 | ||
| Q1 24 | $0.31 | $1.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $869.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $1.4B |
| 总资产 | $2.2B | $12.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHFRHC
| Q4 25 | $429.5M | $869.2M | ||
| Q3 25 | $463.4M | $636.0M | ||
| Q2 25 | $342.1M | $567.9M | ||
| Q1 25 | $260.9M | $837.3M | ||
| Q4 24 | $290.8M | $577.9M | ||
| Q3 24 | $350.3M | $569.2M | ||
| Q2 24 | $327.7M | $718.7M | ||
| Q1 24 | $337.3M | $545.1M |
股东权益ASTHFRHC
| Q4 25 | $779.3M | $1.4B | ||
| Q3 25 | $775.5M | $1.2B | ||
| Q2 25 | $765.5M | $1.2B | ||
| Q1 25 | $745.4M | $1.2B | ||
| Q4 24 | $712.7M | $1.3B | ||
| Q3 24 | $704.6M | $1.3B | ||
| Q2 24 | $678.9M | $1.1B | ||
| Q1 24 | $653.5M | $1.2B |
总资产ASTHFRHC
| Q4 25 | $2.2B | $12.4B | ||
| Q3 25 | $2.2B | $10.3B | ||
| Q2 25 | $1.4B | $9.7B | ||
| Q1 25 | $1.3B | $9.9B | ||
| Q4 24 | $1.4B | $9.1B | ||
| Q3 24 | $1.3B | $8.8B | ||
| Q2 24 | $1.3B | $8.5B | ||
| Q1 24 | $1.2B | $8.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $717.8M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $651.7M |
| 自由现金流率自由现金流/营收 | -0.6% | 103.7% |
| 资本支出强度资本支出/营收 | 0.3% | 10.5% |
| 现金转化率经营现金流/净利润 | -0.44× | 9.42× |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势，按日历期对齐
经营现金流ASTHFRHC
| Q4 25 | $-2.9M | $717.8M | ||
| Q3 25 | $10.0M | $535.3M | ||
| Q2 25 | $90.9M | $480.8M | ||
| Q1 25 | $16.6M | $1.3B | ||
| Q4 24 | $-10.9M | $-72.8M | ||
| Q3 24 | $34.0M | $-438.0M | ||
| Q2 24 | $23.2M | $854.1M | ||
| Q1 24 | $6.0M | $309.0M |
自由现金流ASTHFRHC
| Q4 25 | $-6.0M | $651.7M | ||
| Q3 25 | $7.4M | $456.4M | ||
| Q2 25 | $89.5M | $450.0M | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $-13.5M | $-92.7M | ||
| Q3 24 | $31.7M | $-447.5M | ||
| Q2 24 | $20.4M | $829.9M | ||
| Q1 24 | $5.6M | — |
自由现金流率ASTHFRHC
| Q4 25 | -0.6% | 103.7% | ||
| Q3 25 | 0.8% | 86.7% | ||
| Q2 25 | 13.7% | 84.4% | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.0% | -14.1% | ||
| Q3 24 | 6.6% | -77.0% | ||
| Q2 24 | 4.2% | 184.1% | ||
| Q1 24 | 1.4% | — |
资本支出强度ASTHFRHC
| Q4 25 | 0.3% | 10.5% | ||
| Q3 25 | 0.3% | 15.0% | ||
| Q2 25 | 0.2% | 5.8% | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | 3.0% | ||
| Q3 24 | 0.5% | 1.6% | ||
| Q2 24 | 0.6% | 5.4% | ||
| Q1 24 | 0.1% | — |
现金转化率ASTHFRHC
| Q4 25 | -0.44× | 9.42× | ||
| Q3 25 | 26.69× | 13.82× | ||
| Q2 25 | 9.65× | 15.82× | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | -0.93× | ||
| Q3 24 | 2.11× | -3.82× | ||
| Q2 24 | 1.21× | 24.83× | ||
| Q1 24 | 0.40× | 3.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
FRHC
暂无分部数据
